MiR-29b expression levels were reduced in prostate cancer tissue compared to patient-matched non-tumour tissue, and investigators found increased E-cadherin expression and reduced N-Cadherin, Twist, and Snail expression in cells transfected with miR-29b, suggesting that miR-29b inhibits EMT. The gene discussed is CDH1; the disease is Familial prostate cancer.